(Q38421171)

English

Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

based on heuristic

inferred from title

William R. Hiatt

10

object named as

William R Hiatt

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Eric Olson

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Laura Demopoulos

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Thomas F Haws

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Erding Hu

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Zixing Fang

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Kelly M Mahar

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Pu Qin

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

John Lepore

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Timothy A Bauer

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

6 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Vascular Medicine

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

473-482

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Diagnosis and management of peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Hypoxia-inducible factor 1-related diseases and prospective therapeutic tools

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

The HIF pathway and erythrocytosis

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Hypoxia-inducible factors in physiology and medicine

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Proteins modulation in human skeletal muscle in the early phase of adaptation to hypobaric hypoxia.

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat.

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Heel-rise test in the assessment of individuals with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Prognostic value of functional performance for mortality in patients with peripheral artery disease

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication.

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Chronic changes in skeletal muscle histology and function in peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Muscle oxygenation and ATP turnover when blood flow is impaired by vascular disease

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Mitochondrial function and oxygen supply in normal and in chronically ischemic muscle: a combined 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivo

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Functional, structural and molecular plasticity of mammalian skeletal muscle in response to exercise stimuli

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

The response of human skeletal muscle tissue to hypoxia.

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits

1 reference

https://api.crossref.org/works/10.1177%2F1358863X14557151

21 January 2018

Identifiers

10.1177/1358863X14557151

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38421171&oldid=2098818138"